AI in Medical Imaging Market to Reach $21.6B by 2030, revolutionizing diagnostic accuracy and clinical workflows

Advances in deep learning, computer vision, and cloud-based analytics are cutting turnaround times by up to 30% while boosting detection rates for critical pathologies. According to our forecasts, the AI in Medical Imaging market will grow from approximately $3.9 billion in 2024 to $28.4 billion by 2032, reflecting a 29.9% CAGR.

 

Why This Matters

  • Higher accuracy in detecting diseases (oncology, cardiology, neurology) leads to better patient outcomes.
  • Automated triage speeds emergency diagnoses, easing radiologist shortages.
  • SaaS and cloud-based tools open adoption to mid-tier providers seeking cost-effective solutions.

 

Harness Marketstrat’s proprietary frameworks (TEM, ARC Index, M^3, Compass, GTM Growth Maturity) and data-driven insights to pinpoint where the fastest growth segments

Market Snapshot

    • Global Coverage
      • Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
      • Segmentation: By Modality (CT, MRI, X-ray, Ultrasound, Nuclear), By Clinical Area (Oncology, Cardiology, Neurology, Respiratory, Orthopedics, Others); By Clinical Application (7 applications); By Revenue Stream (Hardware, Software, Service, Cloud/Pay-per-Use); By End-Use Organizations (Hospitals, Imaging Centers, Clinics, Teleradiology, Other); By AI Technology (Deep Learning, Computer Vision, Machine Learning, NLP, Robotics, Expert Systems)
    • Major Figures
      • $28.4B total market size by 2032
      • 29.9% CAGR (2023–2032)
      • Stroke Triage & Chest X-ray among fastest-growing sub-applications
    • Analysis Provided – Markintel™ Methodology and Frameworks
      • Markintel™TEM Technology Evolution Matrix – Market Level
      • Markintel™ ARC Index (Approvals, Reimbursement, Clinical Validation) – Market Level
      • Markintel™ M^3 Market Momentum Matrix – Market Level
      • Markintel™ GTM Growth Maturity Model – Company and Regional Level
      • Markintel™ Technology Diffusion and Impact Timeline (TDIT) – Market Level
      • Markintel™ Solution Adoption and Growth Potential Matrix – Regional Level
      • Markintel™ Regional Readiness Rating – Regional Level
      • Markintel™ 360° Index – Company Level (for leading companies)
      • Markintel™ Ecosystem Collaboration Matrix (ECM) – Company and Region Level
      • Markintel™ Value Creation Framework – (Company Level)
      • Qualitative & Quantitative forecasts, competitor assessments
      • TAM and SAM estimates
      • GTM Playbooks by Region
      • Detailed Competitive Analysis and Standing

 

Bottom Line: The surge in AI adoption is driven by radiologist shortages, regulatory approvals for AI-driven diagnostics, and proven ROI through faster throughput and fewer errors.

Key Market Trends

  1. Real-Time Triage & Workflow Automation
    • Impact: Speeds up ED and radiology diagnoses by 20–30%, improving patient flow.
    • ROI Angle: Stroke triage solutions can reduce read times by up to 25%, saving $50k+ annually in ED staffing.
  2. Multi-Modality AI & Vendor-Neutral Solutions
    • OEM vs. Specialist: OEMs integrate AI directly into scanners; specialized vendors offer standalone software with faster innovation cycles.
    • Integration: Seamless compatibility with existing PACS/VNA ecosystems is a major selling point for vendor-neutral platforms.
  3. SaaS & Cloud Deployments
    • Pay-as-You-Go: Monthly subscription models are attractive for mid-tier hospitals with limited CAPEX.
    • Future Outlook: Cloud-based analytics and HPC (high-performance computing) solutions are accelerating advanced image processing in lower-resource settings.

Competitive Landscape

  • OEM Giants: GE Healthcare, Siemens Healthineers, Philips, Canon, Mindray, United Imaging, Others
    • Strength: End-to-end hardware-software bundles
    • Focus: Integrated radiology suites, broad global presence
  • AI Specialists: Aidoc, Viz.ai, Qure.ai, HeartFlow, Others
    • Strength: Targeted triage (stroke, cardiac, pulmonary) with high-accuracy algorithms
    • Focus: Rapid FDA clearances, forging clinical validation with top hospitals
  • Tech Titans: Microsoft, AWS, Google, Others
    • Strength: Cloud infrastructure, HPC, analytics platforms
    • Focus: Partnerships with OEMs and healthcare providers for AI-driven imaging

What We Cover

  • Company Profiles: Product portfolios, regulatory milestones, market share
  • Markintel Scorecards: Weighted parameters (R&D, geographic reach, interoperability)
  • SWOT Summaries: Where each player excels or faces challenges

Sample Insights & Figures

  • Oncology AI leading with a 29% CAGR, especially in breast & lung detection modules.
  • Stroke triage solutions can reduce read times by up to 25%, saving an average of $50k annually in ED staffing costs.

(The full report includes 100+ charts, region-wise breakdowns, and extensive data tables.)

What’s Inside

  • Executive Summary
    • Key findings, market size overview, top trends
  • Methodology & Assumptions
    • Data sources, Markintel’s frameworks, validation approach
  • Market Overview & Dynamics
    • Growth drivers (radiologist shortage, lower cost), challenges (data privacy, integration)
  • Segmentation Analysis
    • By Clinical Area (oncology, cardiology, neurology, ortho, resp, other)
    • By Imaging Modality (CT, MRI, X-ray, ultrasound, nuclear)
    • By Clinical Application (Improved Diagnostic Accuracy & Classification, Efficiency & Data Handling (Workflow), Early Detection & Abnormality, Prognosis & Treatment (Precision), Image Enhancement & Dose Optimization, Segmentation & Feature Extraction, Integration Across Modalities
    • By Revenue Stream (Hardware, Software, Service, Cloud/Pay-per-Use); By End-Use Organizations (Hospitals, Imaging Centers, Clinics, Teleradiology, Other); 
    • By End-Use Organization (Hospitals, Imaging Centers, Clinics, Teleradiology, Other)
    • By AI Technology (machine learning, deep learning, NLP, etc.)
  • Market Estimates and Forecasts for the above segments by region (By Region (N. America, Europe, APAC, LATAM, MEA)
  • Key Market Trends & Strategic Benefits
    • Emerging vendor-neutral platforms, real-time triage, advanced analytics
    • ROI & case studies
  • Competitive Landscape
    • OEMs, AI specialists, cloud providers
    • Technology evolution & future outlook
  • Recommendations & Case Studies
    • Markintel’s best practices, real-world success stories
  • Appendices & References
    • Data tables, abbreviations, interview quotes

Why This Report?

  1. Accelerated Decision-Making
    • Pinpoint prime growth areas vs. saturated segments using Marketstrat’s proprietary presentations.
  2. Competitive Edge
    • Benchmark R&D spend, product pipelines, and partnership strategies of major players—stay ahead of the curve.
  3. Risk Mitigation
    • Understand how regional regulations and reimbursement policies can impact your AI rollout strategy, avoiding compliance pitfalls.
  4. ROI & Operational Gains
    • Learn from real-world case studies where AI-driven imaging solutions reduce operational costs, boost diagnostic speed, and improve patient outcomes.

Report Details

Forecast Period 2024–2030 (with extended outlook to 2032)
Market Size From $3.9B (2024) to $21.3B (2030) at 27.6% CAGR
Pages ~300 pages (including 100+ charts & tables)
Companies Profiled 35+ (OEMs, AI specialists, tech titans)
Release Date Q1 2025
Geographies Covered N. America, Europe, Asia-Pacific, LATAM, MEA
Custom Region Breakouts Available upon request (add-on)
By submitting this form, you agree to our Privacy Policy
By submitting this form, you agree to our Privacy Policy